Indoco Remedies Limited (BOM:532612)
India · Delayed Price · Currency is INR 202.35
-3.10 (-1.51%)
At close: Feb 13, 2026
Indoco Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -737.37 | 984.6 | 1,423 | 1,548 | 930.46 |
Depreciation & Amortization | 1,037 | 626.83 | 569.35 | 508.58 | 497.89 |
Other Amortization | 101.06 | 291.82 | 136.72 | 263.51 | 233.36 |
Loss (Gain) From Sale of Assets | 5.02 | 3.78 | 12.62 | 5.11 | 2.43 |
Asset Writedown & Restructuring Costs | - | - | - | 17.47 | - |
Loss (Gain) From Sale of Investments | -6.59 | - | - | - | - |
Stock-Based Compensation | 22.01 | 28.8 | 6.58 | - | - |
Provision & Write-off of Bad Debts | 15.9 | 82.56 | 155.97 | 151.36 | 118.56 |
Other Operating Activities | 484.09 | 420.22 | 216.44 | 332.11 | 437.65 |
Change in Accounts Receivable | 506.5 | -637.83 | -787.85 | -587.77 | -402.76 |
Change in Inventory | -662.91 | -270.78 | -154.7 | -726.65 | -295.34 |
Change in Accounts Payable | 545.73 | 301.14 | -86.55 | 214.29 | -507.03 |
Change in Other Net Operating Assets | -361.51 | -277.27 | 297.2 | 12.27 | -193 |
Operating Cash Flow | 949.27 | 1,554 | 1,788 | 1,738 | 822.22 |
Operating Cash Flow Growth | -38.91% | -13.11% | 2.88% | 111.41% | -33.07% |
Capital Expenditures | -3,562 | -4,260 | -2,073 | -1,253 | -768.49 |
Sale of Property, Plant & Equipment | 37.96 | 16.85 | 11.59 | 9.37 | 2.02 |
Investment in Securities | 79.03 | -62.44 | -24.4 | -0.02 | - |
Other Investing Activities | 53.45 | -19.64 | 3.59 | 29.8 | 99.54 |
Investing Cash Flow | -3,391 | -4,325 | -2,082 | -1,214 | -666.93 |
Short-Term Debt Issued | 1,003 | 1,382 | 181.18 | - | 112.48 |
Long-Term Debt Issued | 2,643 | 2,511 | 950 | 975 | 365 |
Total Debt Issued | 3,646 | 3,894 | 1,131 | 975 | 477.48 |
Short-Term Debt Repaid | - | - | - | -139.04 | - |
Long-Term Debt Repaid | -469.66 | -528.66 | -423.94 | -991.83 | -516.3 |
Total Debt Repaid | -469.66 | -528.66 | -423.94 | -1,131 | -516.3 |
Net Debt Issued (Repaid) | 3,176 | 3,365 | 707.24 | -155.86 | -38.82 |
Issuance of Common Stock | 15.9 | 7.73 | - | - | - |
Common Dividends Paid | -139.02 | -207.06 | -207.21 | -137.93 | -27.89 |
Other Financing Activities | -639.11 | -361.38 | -271.99 | -149.93 | -232.03 |
Financing Cash Flow | 2,414 | 2,804 | 228.04 | -443.72 | -298.73 |
Miscellaneous Cash Flow Adjustments | - | 6.25 | - | - | - |
Net Cash Flow | -27.59 | 39.31 | -65.41 | 80.48 | -143.44 |
Free Cash Flow | -2,612 | -2,706 | -284.23 | 485.04 | 53.73 |
Free Cash Flow Growth | - | - | - | 802.73% | -91.66% |
Free Cash Flow Margin | -15.69% | -14.89% | -1.70% | 3.15% | 0.43% |
Free Cash Flow Per Share | -28.33 | -29.33 | -3.08 | 5.26 | 0.58 |
Cash Interest Paid | 639.11 | 361.38 | 271.99 | 149.93 | 232.03 |
Cash Income Tax Paid | 171.22 | 294.86 | 616.54 | 410.81 | 197.19 |
Levered Free Cash Flow | -2,917 | -3,338 | -855.72 | -138.73 | -444.81 |
Unlevered Free Cash Flow | -2,530 | -3,120 | -707.28 | -35.87 | -313.3 |
Change in Working Capital | 27.82 | -884.74 | -731.89 | -1,088 | -1,398 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.